About this document
Shen, 2022 by namiyaguti is a document available to read on EtoBox.
This study investigates the use of spatial metabolomics to evaluate the response to neoadjuvant chemotherapy (NAC) in non-small cell lung cancer (NSCLC) patients. By analyzing resected tissue specimens, the researchers developed metabolic classifiers that demonstrated higher prognostic accuracy compared to traditional methods like major pathological response (MPR) and TNM staging. The findings suggest that metabolic profiling of tumor cells and stroma can enhance the assessment of treatment responses and pa
- Author
- namiyaguti
- Language
- EN